Enzo Biochem, Inc.
ENZB · OTC
7/31/2024 | 7/31/2023 | 7/31/2022 | 7/31/2021 | |
|---|---|---|---|---|
| Market Cap | $58 | $73 | $118 | $157 |
| - Cash | $52 | $82 | $22 | $14 |
| + Debt | $4 | $7 | $21 | $23 |
| Enterprise Value | $9 | -$3 | $117 | $166 |
| Revenue | $32 | $31 | $107 | $118 |
| % Growth | 2.7% | -71% | -9.1% | – |
| Gross Profit | $15 | $12 | $42 | $54 |
| % Margin | 45.9% | 37.2% | 39.2% | 45.5% |
| EBITDA | -$8 | -$22 | -$15 | $3 |
| % Margin | -26.2% | -71.9% | -14% | 2.8% |
| Net Income | -$26 | $20 | -$23 | $3 |
| % Margin | -81.7% | 65.3% | -21.1% | 2.9% |
| EPS Diluted | -0.51 | -1.27 | -0.46 | 0.071 |
| % Growth | 59.8% | -176.1% | -748.8% | – |
| Operating Cash Flow | -$26 | -$37 | -$17 | $0 |
| Capital Expenditures | -$1 | -$3 | -$3 | -$4 |
| Free Cash Flow | -$27 | -$40 | -$20 | -$4 |